Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
Clinical trial NCT00086203 · COMPLETED
Trial details
- NCT number
- NCT00086203
- Sponsor
- Point Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.